Genotech Corporation (XKON:066830)

Market Cap	8.33B +6.4%
Revenue (ttm)	7.28B +11.4%
Net Income	-1.32B
EPS	-280.00
Shares Out	5.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	312
Average Volume	3,390
Open	1,499.00
Previous Close	1,400.00
Day's Range	1,301.00 - 1,499.00
52-Week Range	805.00 - 1,601.00
Beta	0.18
RSI	74.95
Earnings Date	n/a

About Genotech

Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services. It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagn...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 066830

Financial Performance

In 2015, Genotech's revenue was 7.28 billion, an increase of 12.91% compared to the previous year's 6.45 billion. Losses were -1.32 billion, 250.7% more than in 2014.